← Leaderboards
Tarek I Hassanein
University Of California San Diego
$4,213
Attributed
$4,213
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$4,213 · 3
By mechanism
M01$4,213 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Igor Grant$65,384,704
- Jerrold M Olefsky$29,583,289
- John C Gillin$665,812
- Robert Roy Henry$4,115,619
- Michael R Irwin$42,103,262
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchCombination ChemotherapyHepatitis CHepatitis C VirusHuman SubjectHuman Therapy EvaluationInterferon AlphaMicroorganism Disease ChemotherapyRibavirin
Grant awards (18)
N-ACETYLCYSTEINE IN THE TREATMENT OF ACUTE LIVER FAILURE IN ADULTS$4,213
M01 · FY2005 · RR
IFN ALPHA-2B + RIBAVIRIN VS REBETRON IN HEPATITIS C$0
M01 · FY2002 · RR
IFN ALPHA-2B + RIBAVIRIN VS REBETRON IN HEPATITIS C$0
M01 · FY2002 · RR
IFN ALPHA-2B + RIBAVIRIN VS REBETRON IN HEPATITIS C$0
M01 · FY2002 · RR
IFN ALPHA-2B + RIBAVIRIN VS REBETRON IN HEPATITIS C$0
M01 · FY2002 · RR
RIBAVIRIN VS PEGINTERFERON ALPHA-2A + RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2002 · RR
RIBAVIRIN VS PEGINTERFERON ALPHA-2A + RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2002 · RR
RIBAVIRIN VS PEGINTERFERON ALPHA-2A + RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2002 · RR
RIBAVIRIN VS PEGINTERFERON ALPHA-2A + RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2002 · RR
IFN ALPHA-2B + RIBAVIRIN VS REBETRON IN HEPATITIS C$0
M01 · FY2001 · RR
IFN ALPHA-2B + RIBAVIRIN VS REBETRON IN HEPATITIS C$0
M01 · FY2001 · RR
RIBAVIRIN VS PEGINTERFERON ALPHA-2A + RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2001 · RR
RIBAVIRIN VS PEGINTERFERON ALPHA-2A + RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2001 · RR
IFN ALPHA-2B + RIBAVIRIN VS REBETRON IN HEPATITIS C$0
M01 · FY2000 · RR
RIBAVIRIN VS PEGINTERFERON ALPHA-2A + RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2000 · RR
IFN ALPHA-2B + RIBAVIRIN VS REBETRON IN HEPATITIS C$0
M01 · FY2000 · RR
IFN ALPHA-2B + RIBAVIRIN VS REBETRON IN HEPATITIS C$0
M01 · FY2000 · RR
RIBAVIRIN VS PEGINTERFERON ALPHA-2A + RIBAVIRIN IN CHRONIC HEPATITIS C INFECTION$0
M01 · FY2000 · RR